Sitagliptin vs Atorvastatin: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Atorvastatin (HMG-CoA reductase inhibitor (statin)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Atorvastatin |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | HMG-CoA reductase inhibitor (statin) |
| CAS | 486460-32-6 | 134523-00-5 |
| ATC | A10BH01 | C10AA05 |
| Molecular weight | 407.31 g/mol | 558.65 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Atorvastatin share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Atorvastatin, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: Sitagliptin hemmt reversibel DPP-4, die Serinprotease, die für den schnellen Abbau von Glucagon-like Peptid 1 (GLP-1) und glukoseabhängigem insulinotropen Polypeptid (GIP) verantwortlich ist. Atorvastatin: Atorvastatin hemmt kompetitiv die HMG-CoA-Reduktase, das geschwindigkeitsbestimmende Enzym der hepatischen Cholesterinsynthese.
Indications compared
Sitagliptin: Sitagliptin ist bei Erwachsenen mit Typ-2-Diabetes mellitus, allein oder in Kombination mit anderen antidiabetischen Wirkstoffen, zur Verbesserung der glykämischen Kontrolle zugelassen. Atorvastatin: Atorvastatin ist bei Erwachsenen zur Behandlung der primären Hypercholesterinämie und der gemischten Dyslipidämie, zur Prävention kardiovaskulärer Ereignisse bei Patienten mit erhöhtem Risiko sowie zur Sekundärprävention…
Safety profile
Sitagliptin: Sitagliptin wird im Allgemeinen gut vertragen. Atorvastatin: Häufige Nebenwirkungen sind Myalgien, gastrointestinale Beschwerden und leichte Erhöhungen der Leberenzyme.
Häufig gestellte Fragen
Is Sitagliptin better than Atorvastatin? ▾
Sitagliptin and Atorvastatin are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Atorvastatin be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Atorvastatin
Die Informationen auf dieser Website dienen ausschließlich zu Referenz- und Bildungszwecken. Sie ersetzen nicht die Beratung durch qualifiziertes medizinisches Fachpersonal.